Amgen (AMGN)

R&D Expenses

$1.87B

Quarterly · Period ending: · USD

AMGN logo

AMGN R&D Expenses

Latest reported$1.87B
AMGN Quarterly R&D Expenses ($0.00 → $1.87B)
High-resolution chart · PNG

AMGN r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
1,868,000,000
1,719,000,000
2,151,000,000
1,900,000,000
1,744,000,000
1,486,000,000
1,724,000,000
1,450,000,000
1,447,000,000
1,343,000,000
1,534,000,000
1,079,000,000
1,113,000,000
1,058,000,000
1,324,000,000
1,112,000,000
1,039,000,000
959,000,000
1,348,000,000
1,422,000,000
1,082,000,000
967,000,000
1,229,000,000
1,062,000,000
964,000,000
952,000,000
1,312,000,000
1,001,000,000
924,000,000
879,000,000
1,182,000,000
926,000,000
869,000,000
760,000,000
1,043,000,000
877,000,000
873,000,000
769,000,000
1,078,000,000
990,000,000
900,000,000
872,000,000
1,093,000,000
1,119,000,000
964,000,000
894,000,000
1,234,000,000
1,018,000,000
1,018,000,000
1,027,000,000
1,249,000,000
989,000,000
967,000,000
878,000,000
938,000,000
880,000,000
826,000,000
736,000,000
851,000,000
761,000,000
819,000,000
736,000,000
854,000,000
719,000,000
675,000,000
646,000,000
891,000,000
647,000,000
693,000,000
633,000,000
798,000,000
729,000,000
809,000,000
694,000,000
822,000,000
776,000,000
817,000,000
851,000,000
1,051,000,000
872,000,000
788,000,000
655,000,000
661,000,000
562,000,000
567,000,000
524,000,000
617,000,000
502,000,000
468,000,000
441,000,000
502,900,000
408,000,000
393,700,000
351,300,000
367,000,000
312,600,000
233,600,000
203,400,000
232,600,000
216,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.